| Literature DB >> 31435341 |
Abeer Al-Namankany1, Abrar Alhubaishi1.
Abstract
OBJECTIVES: This study aimed to evaluate the psychological effects of cleft lip and palate (CLP) on children and their parents and to determine any relationship between social support and timing of surgical repairs for these defects.Entities:
Keywords: Children; Cleft; Lip; Palate; Psychological
Year: 2018 PMID: 31435341 PMCID: PMC6694901 DOI: 10.1016/j.jtumed.2018.04.007
Source DB: PubMed Journal: J Taibah Univ Med Sci ISSN: 1658-3612
PRISMA checklist.
| Section/topic | # | Checklist item | Reported on page # |
|---|---|---|---|
| Title | 1 | Identify the report as a systematic review, meta-analysis or both. | 1 |
| Structured summary | 2 | Provide a structured summary including background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions and implications of key findings, and a systematic review registration number, as applicable. | 2 |
| Rationale | 3 | Describe the rationale for the review in the context of what is already known. | 3 |
| Objectives | 4 | Provide an explicit statement of questions addressed according to participants, interventions, comparisons, outcomes and study design (PICOS). | 4 |
| Protocol and registration | 5 | Indicate if a review protocol exists, if and where it can be accessed (e.g. Web address) and, if available, provide registration information including a registration number. | N/A |
| Eligibility criteria | 6 | Specify the study characteristics (e.g. PICOS, length of follow-up) and report characteristics (e.g. years considered, language, publication status) used as criteria for eligibility and provide a rationale for use. | 5 |
| Information sources | 7 | Describe all the information sources (e.g. databases with dates of coverage, contact with the research authors to identify additional studies) used in the search and the date they were last searched. | 5 |
| Search | 8 | Present a full electronic search strategy for at least one database, including any limits used so that it could be repeated. | 5 |
| Study selection | 9 | State the process for selecting studies (i.e. screening, eligibility, inclusion in the systematic review and, if applicable, inclusion in the meta-analysis). | 5 |
| Data collection process | 10 | Describe the method of data extraction from reports (e.g. piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators. | 5 |
| Data items | 11 | List and define all the variables for which data were sought (e.g. PICOS, funding sources) and any assumptions and simplifications made. | N/A |
| Risk of bias in individual studies | 12 | Describe the methods used for assessing individual studies' risk of bias (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis. | N/A |
| Summary measures | 13 | State the principal summary measures (e.g. risk ratio, difference in means). | N/A |
| Synthesis of results | 14 | Describe the methods of handling data and combining the results of studies, if this occurred, including measures of consistency (e.g. I2) for each meta-analysis. | N/A |
| Risk of bias across studies | 15 | Specify any assessment of risk of bias that may affect the cumulative evidence (e.g. publication bias, selective reporting within studies). | N/A |
| Additional analyses | 16 | Describe the methods of additional analyses (e.g. sensitivity or subgroup analysis, meta-regression), if these occurred, indicating which were pre-specified. | N/A |
| Study selection | 17 | Provide the numbers of studies screened, assessed for eligibility and included in the review, with reasons for exclusions at each stage ideally with a flow diagram. | 6 |
| Study characteristics | 18 | For each study, present characteristics for which data were extracted (e.g. study size, PICOS, follow-up period) and provide citations. | N/A |
| Risk of bias within studies | 19 | Present the data on risk of bias of each study and, if available, any outcome level assessment (see item 12). | N/A |
| Results of individual studies | 20 | For all outcomes considered (benefits or harms) and for each study present (a) simple summary data for each intervention group and (b) effect estimates and confidence intervals, ideally with a forest plot. | 6–9 |
| Synthesis of results | 21 | Present results of each meta-analysis done including confidence intervals and measures of consistency. | N/A |
| Risk of bias across studies | 22 | Present results of any assessment of risk of bias across studies (see Item 15). | N/A |
| Additional analysis | 23 | Provide results of additional analyses, if these occurred (e.g. sensitivity or subgroup analyses, meta-regression [see Item 16]). | N/A |
| Summary of evidence | 24 | Summarise the main findings including the strength of evidence for each main outcome and consider their relevance to key groups (e.g. healthcare providers, users, policy makers). | 10 |
| Limitations | 25 | Discuss limitations at the study, outcome level (e.g. risk of bias) and review level (e.g. incomplete retrieval of identified research, reporting bias). | 10 |
| Conclusions | 26 | Provide a general interpretation of the results in the context of other evidence and implications for future research. | 11 |
| Funding | 27 | Describe sources of funding for the systematic review, other support (e.g. supply of data) and the role of funders for the systematic review. | No Funding |
Figure 1Articles flow diagram.
Summary of the 26 included articles.
| First author | Year of publication | Country | Participants' age | Sample size | Main findings | Presence of psychological problems |
|---|---|---|---|---|---|---|
| 1-Stock NM | 2016 | United Kingdom | Diagnosis at 18 months, 3 years, 5 years and 8 years old | Not reported | Adjustment and other risk/protective factors that are measurable across key developmental periods | Yes |
| 2-Feragen KB | 2015 | United Kingdom | 16 years | 857 | Cognitive, emotional, behavioural, appearance-related and psychosocial adjustment | Yes |
| 3-Feragen KB | 2016 | United Kingdom | 10 years | 845 | Satisfaction with appearance and associated conditions | No |
| 4-Nilsson S | 2012 | Sweden | Children born in 1987–1993 until 1st of January 2008 | Not reported | Psychological health of children and their mothers, and wither the higher effect of CL alone or associated with OFC | Yes |
| 5-Klassen AF | 2011 | United Kingdom | Not reported | Ranged from 23 to 661 in 9 countries | Quality of life involving physical, psychological and social aspects | Yes |
| 6-Feragen KB | 2014 | United Kingdom | 10 years | Not reported | Visibility of the cleft, adjustment and associated conditions | Yes |
| 7-Chimruang J | 2011 | Thailand | Not reported | 18 | Parental support, physical symptoms, functional limitations, emotional wellbeing and social wellbeing | Yes |
| 8-Hexem KR | 2013 | Tegucigalpa, Honduras | Not reported | 45 | Expectations of parents about feeding, speech and overall wellbeing of their children, and postoperative satisfaction. | Yes |
| 9-Pradubwong S | 2014 | Thailand | 5–6 years | 39 | Quality of life, speech, hearing, dental treatment and communication skills | No |
| 10-Broder HL | 2014 | United States | 11.8 years (mean) | 1200 | Preoperative psychological health | Yes |
| 11-Mahalingam S | 2013 | United Kingdom | Not reported | 24 | Ethnic group, effect of teasing and bullying on the child self-esteem | Yes |
| 12-Chua HD | 2012 | Hong Kong | Not reported | Not reported | Comparison of maxillary distraction osteogenesis and conventional orthognathic surgery and patients satisfaction. | Yes |
| 13-Lorot-Marchand | 2015 | United States | 15 years (mean) | 55 | Taunting, daily lives, self-perception and effect on educational level | Yes |
| 14-Jeong JH | 2013 | Korea | Not reported | 36 | Psychological states and stress levels of the Korean mothers of CLP patients | Yes |
| 15-Wang Y | 2013 | China | Not reported | 102 | Significance of somatisation, obsessive-compulsive symptoms, depression and anxiety among mothers | Yes |
| 16-Grollemund B | 2012 | France | Parents and children were seen twice, when the child is 4 months old and when the child was one year old | Not reported | Child distress, withdrawal, importance of prenatal diagnosis, relational development with the child, self-image and quality of life. | Yes |
| 17-Hasanzadeh N | 2014 | Iran | Not reported | 55 | Coping strategies and psychological distress among mothers | Yes |
| 18-Feragen KB | 2014 | United Kingdom | Not reported | 754 | Prevalence of conditions that affect cognitive and/or psychosocial functioning | Yes |
| 19-Broder HL | 2014 | United States | 11.8 years (mean) | 1200 | Self-esteem and it's relation | Yes |
| 20-Wang Y | 2009 | United States | Not reported | 204 | Anxiety and depression among parents | Yes |
| 21-Gajarao HM | 2015 | India | Not reported | 60 | Psychiatric problems among mothers | Yes |
| 22-Beluci ML | 2016 | Sau Paulo, Brazil | Not reported | 50 | Psychological disability, social disability and physical handicap | Yes |
| 23-Alansari R | 2014 | KSA | Not reported | 11 | Stigma, negative self-perception and defectiveness | Yes |
| 24-Augsornwan D | 2011 | Thailand | 8–18 years | 15 | Postoperative self-perception, worrying about scaring and further treatment | No |
| 25-Zamora Linares CE | 2010 | Spain | 10 years | 92 | Self-esteem and dependence on others | Yes |
| 26-Gong C | 2011 | China | Not reported | 100 | Effect of psychological counselling among parents | Yes |